Thrombin inhibition by dabigatran attenuates endothelial dysfunction in diabetic mice

Arief Rahadian(Tokushima University), Masataka Sata(Tokushima University)

Vascular Pharmacology

November 20, 2019

10.1016/j.vph.2019.106632

Cited by 32

Related Papers

NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload

|Circulation|2022|191

Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse

|Frontiers in Cardiovascular Medicine|2016|115

Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice

|Journal of Atherosclerosis and Thrombosis|2020|62

Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser1177/Thr497 of endothelial nitric oxide synthase in diabetic mice

|Cardiovascular Diabetology|2014|61

Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice

|Vascular Pharmacology|2015|56